Literature DB >> 21686829

Diffuse mesangial IgA glomerulonephritis in a patient with rheumatoid arthritis: a possible extra-articular manifestation in rheumatoid arthritis.

Lyubomir Marinchev1, Svetla Atanasova, Raina Robeva, Todor Todorov.   

Abstract

Rheumatoid arthritis (RA) is an inflammatory joint disease, in which, unlike systemic lupus erythematosus (SLE), renal involvement is uncommon. The major causes of renal disease in RA are usually linked to amyloid or secondary effects of drugs. Nevertheless the relation between IgA, IgA-rheumatoid factor (RF) and renal disease in patients with RA is not clear, but the affinity of IgA for mesangium, skin and synovium might explain clinical presentation of RA with mesangial IgA glomerulonephritis. The case of a 42-year-old Caucasian man with RA and diffuse mesangial IgA glomerulonephritis proven by renal biopsy is presented. The patient was treated with boluses of methylprednisolone 1000 mg and cyclophosphamide 1000 mg monthly for 13 months. Between boluses there was a supported therapy with methylprednisolone 8 mg/day. After a year of treatment full clinical and laboratory remission of RA and IgA glomerulonephritis was achieved. Pathogenic therapy will be stopped and the patient followed-up.

Entities:  

Year:  2009        PMID: 21686829      PMCID: PMC3027824          DOI: 10.1136/bcr.07.2008.0394

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

Authors:  Francis W Ballardie; Ian S D Roberts
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

Review 2.  Rheumatoid arthritis associated with membranous nephropathy and IgA nephritis with necrotizing lesions.

Authors:  F Irie; M Kobayashi; K Hirayama; S Nagase; T Iitsuka; N Yamaguchi; A Koyama
Journal:  Nephrol Dial Transplant       Date:  1996-07       Impact factor: 5.992

3.  Mesangial glomerulopathy and IgM rheumatoid factor in rheumatoid arthritis.

Authors:  S Pollet; T Depner; P Moore; H Olander; D Robbins
Journal:  Nephron       Date:  1989       Impact factor: 2.847

4.  Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.

Authors:  K Tsuruya; A Harada; H Hirakata; K Mitsuiki; T Johko; H Kondoh; S Takechi; M Fujishima
Journal:  Clin Nephrol       Date:  2000-01       Impact factor: 0.975

5.  Glomerulonephritis in rheumatoid arthritis.

Authors:  D Adu; F Berisa; A J Howie; P Emery; P A Bacon; B McConkey; R J McGonigle; J Michaels; A J Popert
Journal:  Br J Rheumatol       Date:  1993-11

6.  Mild mesangial glomerulopathy--a frequent finding in rheumatoid arthritis patients with hematuria or proteinuria.

Authors:  H Helin; M Korpela; J Mustonen; A Pasternack
Journal:  Nephron       Date:  1986       Impact factor: 2.847

7.  Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.

Authors:  Franz Maximilian Rasche; Christoph Hubert Klotz; David Czock; Wolfram Karges; Rainer Muche; Peter Michael Jehle; Andreas Mertz; Frieder Keller
Journal:  Nephron Clin Pract       Date:  2003

8.  Mesangial glomerulopathy in rheumatoid arthritis patients. Clinical follow-up and relation to antirheumatic therapy.

Authors:  M Korpela; J Mustonen; A Pasternack; H Helin
Journal:  Nephron       Date:  1991       Impact factor: 2.847

9.  Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.

Authors:  M Nakano; M Ueno; S Nishi; H Shimada; H Hasegawa; T Watanabe; T Kuroda; T Sato; Y Maruyama; M Arakawa
Journal:  Clin Nephrol       Date:  1998-09       Impact factor: 0.975

10.  Haematuria in rheumatoid arthritis: a follow up study.

Authors:  C A Kelly; P Mooney; L D Hordon; I D Griffiths
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

View more
  1 in total

1.  Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.

Authors:  Kazunori Karasawa; Yuko Iwabuchi; Mizuki Kyoda; Taro Akihisa; Erika Yamaguchi; Shunji Suzuki; Shota Ogura; Tomo Takabe; Yoei Miyabe; Takahiro Kamiyama; Marie Nakano; Shun Manabe; Michiaki Kamiyama; Kenichi Akiyama; Masayo Sato; Keiko Uchida; Kosaku Nitta; Takahito Moriyama
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.